Growing diabetes prevalence, with over 540 million diagnosed individuals worldwide, and the increasing adoption of continuous subcutaneous insulin infusion (CSII) therapy are fueling market demand.
Adults with type 2 diabetes who used an automated insulin delivery system had greater improvements in HbA1c than controls ...
The Enquirer is investigating readers’ medical bills. For our first story, we talked to Ashley Hack, the mom of a 12-year-old with Type 1 diabetes. Do you have a bill you want us to check out? Email ...
This report provides an in-depth analysis of the insulin pump market, highlighting key trends in pricing, manufacturing, and ...
The 510(k) decision clears the device for use with ultra-rapid-acting insulins from Eli Lilly and Novo Nordisk.
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM) and Dexcom, Inc. (Nasdaq: DXCM), today announced that the Tandem Mobi insulin pump with Control-IQ technology is now fully ...
Detailed price information for Modular Medical Inc (MODD-Q) from The Globe and Mail including charting and trades.
Medtronic has recalled some of its insulin pumps after injuries and one death were reported due to the device malfunctioning, according to a US Food and Drug Administration announcement on Wednesday.
More than 200 people with diabetes were injured after technology defect caused their insulin pump to unexpectedly shut down, according to the Food and Drug Administration. The software glitch has ...
The US Food and Drug Administration (FDA) has issued a Class I recall for the t:connect mobile app on iOS, which is used to monitor and control the t:slim X2 insulin pump used by people with diabetes.
This Aug. 2, 2018, file photo shows the U.S. Food and Drug Administration building behind FDA logos at a bus stop on the agency's campus in Silver Spring, Md. AP Photo/Jacquelyn Martin, File SILVER ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results